WardNSBranderFKellyK. Intensive upper limb neurorehabilitation in chronic stroke: outcomes from the Queen Square programme. J Neurol Neurosurg Psychiatry2019; 90: 498–506.
2.
AVERT Trial Collaboration group. Efficacy and safety of very early mobilisation within 24 h of stroke onset (AVERT): a randomised controlled trial. Lancet2015; 386: 46–55.
3.
Godecke E, Armstrong E, Rai T, et al.; VERSE Collaborative Group. A randomized control trial of intensive aphasia therapy after acute stroke: the Very Early Rehabilitation for SpEech (VERSE) study. Int J Stroke 2021; 16(5): 554–570.
4.
GodeckeEHirdKLalorEERaiTPhillipsMR. Very early poststroke aphasia therapy: a pilot randomized controlled efficacy trial. Int J Stroke2012; 7: 635–644.
5.
Tay J, Morris RG and Markus HS. Apathy after stroke: diagnosis, mechanisms, consequences, and treatment. Int J Stroke 2021; 16(5): 508–516.
6.
BaronJCMarkusHSPickardJDDavisSMDonnanGA. Lindsay Symon: a giant of stroke. Int J Stroke2020; 15: 356–360.
7.
Ermine CM, Bivard A, Parsons MW and Baron JC. The ischemic penumbra: From concept to reality. Int J Stroke 2021; 16(5): 495–507.
